https://www.biocentury.com/article/67585/neurocrine-preclinical-data
BioCentury - Neurocrine preclinical data
FDA researchers and colleagues published in Nature Medicine the ability of an IL-4 fusion toxin to produce complete responses in mice with subcutaneous KS ...
neurocrinepreclinicaldata
https://www.fiercebiotech.com/biotech/abbott-and-neurocrine-announce-global-agreement-to-develop-and-commercialize-elagolix-for-0
Abbott and Neurocrine Announce Global Agreement to Develop and Commercialize Elagolix for the...
Jun 16, 2010 - ABBOTT PARK, Ill. and SAN DIEGO, June 16 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) and Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that they...
for theabbottneurocrineannounceglobal
https://nirisd.org/neurocrine/
Neurocrine - NIRI San Diego
san diegoneurocrineniri
https://13finsight.com/news/benevich-nbix-47m-career-insider-sales
NEUROCRINE BIOSCIENCES INC insider flow update: BENEVICH ERIC's post-2026-01-31 transaction pattern...
Mar 5, 2026 - BENEVICH ERIC's NBIX insider record stands at $47.0M cumulative sales (latest filing 2026-01-31); focus on sequence, transaction-code mix, and ownership trend o
neurocrine biosciences incinsiderflowupdateeric
https://www.neurocrine.com/pipeline/
Pipeline | Neurocrine Biosciences
neurocrine biosciencespipeline
https://lifesciencetracker.com/entries/neurocrine-biosciences-inc-7-30-2025/
Neurocrine Biosciences Inc - 7/30/2025 - Incubate Investment Tracker
Sep 9, 2025 - AUSTEDO and AUSTEDO XR, marketed by Teva Pharmaceuticals Industries, have been selected for the Medicare drug negotiation program in 2025 (for initial price...
neurocrine biosciences incincubateinvestmenttracker